Home » Attend

Attend

Patient Empowerment World Congress 2025 Europe

“The importance of Patient Empowerment in pharma and healthcare in achieving improved health outcomes, building greater trust, and driving innovation within the industry"

Hilton London Kensington, London, United Kingdom

Thursday 25th - Friday 26th September 2025

FACILITATE LIVE is very pleased to welcome you to our upcoming PATIENT EMPOWERMENT World Congress 2025 Europe. The congress focuses on “The importance of Patient Empowerment in pharma and healthcare in achieving improved health outcomes, building greater trust, and driving innovation within the industry”.

Involving patients in their treatment decisions and ensuring their understanding of care plans greatly enhances adherence to prescribed medications and therapies. This approach, integrating shared decision-making with comprehensive patient education, enables individuals to make informed choices, leading to improved health outcomes. The advantages of patient empowerment are extensive, including quicker recovery times, reduced anxiety, and an increased likelihood of patients proactively managing their health through healthier lifestyle choices and effective condition monitoring.

When patients feel heard and respected, it strengthens their bond with healthcare providers, fostering more open communication and better collaboration. Engaging with patients and demonstrating a commitment to their needs builds trust and cultivates positive perceptions of the pharmaceutical industry. Patient empowerment necessitates transparency in research, development, and treatment information, achievable through clear communication and accessible resources. Patient input is invaluable for driving innovation and efficiency in healthcare, as it helps identify unmet needs, design more effective clinical trials, and develop new therapies that are truly relevant to patients’ lives. When patients are actively involved in the research process, they are more likely to participate in clinical trials and remain engaged throughout the study.

By understanding patient preferences and experiences, pharmaceutical companies can develop more personalized and effective treatments and support programs. Furthermore, empowered patients can provide valuable feedback on patient support programs, aiding in their refinement and improvement. Patient empowerment aligns with ethical principles that respect individual autonomy, enabling patients to make informed decisions about their health. By ensuring all patients have access to the necessary information and support, patient empowerment can help address health disparities and promote health equity. Ultimately, patient empowerment is a key driver in moving towards a healthcare system where patients are active participants and their needs are at the center of care.

The two-day Congress aims to foster significant conversations and collaborations among various key stakeholders, including those in the healthcare and pharma industries, advocacy groups, clinicians, researchers, and, most importantly, patients and their caregivers.

We will focus on patient empowerment and its implications for both patients and the pharmaceutical and life science industries. I hope this event will spark insightful discussions

We look forward to meeting you at the Congress!

GAIN LATEST INSIGHTS ON:

  • Collaborative decision-making measures to ensure patients, pharma and healthcare providers work together to make informed treatment decisions, recognizing patients as equal partners.
  • Providing clear and accessible information to patients about their conditions, treatments, and available options to empower their active participation.
  • Patient involvement in treatment decisions and understanding of care plans improves adherence to medication and therapies.
  • Fostering more open communication and better collaboration with healthcare providers ensuring they feel heard and understood.
  • Patient input is crucial for healthcare innovation to help identify unmet needs, design better clinical trials, and develop more relevant therapies.
  • Actively engaging patients in the research process to increase participation, better trial outcomes, and a more patient-centred research environment.
  • Pharmaceutical companies can develop more personalized and effective treatments and support programs by understanding patient preferences and experiences,
  • Shifting approach from a paternalistic model to a collaborative approach that places patients at the center of their healthcare journey.
  • Strategies to encourage healthcare professionals to develop the skills and attitudes necessary for adapting to the evolving role of patients.
  • Addressing health disparities and promote health equity by ensuring all patients have access to the necessary information and support
  • Role of researchers in bridging the communication gap between life science industry and the patient it serves
  • How to achieve a deeper understanding of the patient experience in the real world

WHO SHOULD ATTEND?

This Congress is beneficial to pharmaceutical, biotech companies, researchers, physicians, patient advocacy groups, regulatory agencies, technology and healthcare companies.

Network with Presidents, Heads/Chiefs, VPs, Directors, and Leaders in the area of:

  • Patients
  • Patient Engagement
  • Patient Services
  • Engagement Strategy
  • R&D Patient Engagement
  • Medical Affairs
  • Commercialisation
  • Marketing
  • Regulatory Affairs and Policy
  • Patient Support
  • RWE, and Data Management
  • Quality and Compliance
  • Clinical Development and Operations
  • Programme Management
  • Supply Chain Management
  • Patient Access
  • Clinical Research
  • Digital Accelerator
  • Patient Engagement & Portfolio Strategy
  • Patient Support
  • Strategy & Insights
  • Patient Experience
  • Global Patient Advocacy & Alliances
  • Government Policy and Advocacy
  • Digital Patient Experience Lead
  • Clinical Insights and Experience
  • Head of Strategy, Access Services
  • Site Collaborations and Patient Centricity

Delegate Tickets

Group Discounts Are Also Available

Patients / Patient Group

Subject To Approval
Free
  • Full Access - 2 Day Conference
  • All Day Refreshments & Lunches
  • Conference Documentations
  • Networking Drinks Reception

Non Profit / Acedemic

Verification Required
£499
  • Full Access - 2 Day Conference
  • All Day Refreshments & Lunches
  • Conference Documentations
  • Networking Drinks Reception

Standard Vendor Registration Rate

Vendors / Service / Solution Providers / Consultants / CRO's
£1999
  • Full Access - 2 Day Conference
  • All Day Refreshments & Lunches
  • Conference Documentations
  • Networking Drinks Reception

Standard Registration Rate

Pharma / Biotech
£1299
  • Full Access - 2 Day Conference
  • All Day Refreshments & Lunches
  • Conference Documentations
  • Networking Drinks Reception
Scroll to Top